The company is not selling any shares of its common stock under this prospectus and will not receive any of the proceeds from the sale of the ...
HK-listed stocks related to theme of minimally-invasive medical treatment rallied across the board this morning (14th), with ...
Q4 2024 Earnings Call Transcript March 12, 2025 Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $0.06, ...
19h
March 13 marks the birthday of one of Canada’s greatest writers, W.O. Mitchell. His most famous book, Who Has Seen the Wind, was released in 1947 and over the years it sold close to one million copies ...
It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...
Lynn Potyen is the owner of The GameBoard in Sheboygan, a shop specializing in board game sales—specifically those not found ...
3hon MSN
Motherhood has fundamentally shaped Dr Madan’s leadership style. It has instilled in her a drive to move forward, a deep well ...
The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...
Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...
The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback